KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹69 Cr | ₹69 Cr | ₹73 Cr | ₹22 Cr | ₹20 Cr |
What is the latest Total Current Liabilities ratio of KILITCH DRUGS (INDIA) ?
Year | Total Current Liabilities |
---|---|
Mar2023 | ₹69 Cr |
Mar2022 | ₹69 Cr |
Mar2021 | ₹73 Cr |
Mar2020 | ₹22 Cr |
Mar2019 | ₹20 Cr |
How is Total Current Liabilities of KILITCH DRUGS (INDIA) Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹69 Cr | -0.59 | |
Mar2022 | ₹69 Cr | -5.51 | |
Mar2021 | ₹73 Cr | 233.68 | |
Mar2020 | ₹22 Cr | 9.35 | |
Mar2019 | ₹20 Cr | - |
Compare Total Current Liabilities of peers of KILITCH DRUGS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KILITCH DRUGS (INDIA) | ₹579.7 Cr | 3% | -7.7% | 114.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
KILITCH DRUGS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KILITCH DRUGS (INDIA) | 3% |
-7.7% |
114.5% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses